AUBN vs FNWB

AUBN exhibits a Piotroski F-Score of 4/9, indicating stable but not robust financial health, while the absence of an Altman Z-Score limits distress risk assessment. The stock trades below its Graham Number of $34.65 at $26.25, suggesting potential undervaluation, though growth expectations are modest with a P/E of 12.62 and strong recent earnings growth. Profitability metrics like a 22.11% profit margin and 32.92% operating margin are solid, but low ROA of 0.71% and missing leverage data raise concerns. Dividend strength is high with a 4.17% yield and sustainable 52.68% payout ratio, but technical trend is bearish and insider sentiment is neutral.

FNWB exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. While the stock trades at a deep discount to book value (P/B 0.56) and shows impressive YoY revenue growth of 63.6%, these are overshadowed by negative ROE (-2.69%) and a profit margin of -6.92%. Furthermore, the dividend is unsustainable with a payout ratio of 107.69%, suggesting the company is paying out more than it earns. Despite a positive analyst target price, the deterministic health metrics signal high risk.